Grufity logo
Grufity logo

Latest Vivo Capital, LLC Stock Portfolio

$1.20Billion | No. of Holdings #46

Vivo Capital, LLC Performance

2026 Q1+17.56%
YTD+17.56%
2025+125.64%

About Vivo Capital, LLC and 13F Hedge Fund Stock Holdings

Vivo Capital, LLC is a hedge fund based in Palo Alto, CA. On 2026-05-20, the fund reported it's updated stock portfolio. In the 13F Holdings report, Vivo Capital, LLC reported an equity portfolio of $1.2 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of Vivo Capital, LLC are ERAS, PRAX, TERN. The fund has invested 16.3% of it's portfolio in ERASCA INC and 9.1% of portfolio in PRAXIS PRECISION MEDICINES. <br><br> The fund managers got completely rid off CIDARA THERAPEUTICS, INC. (CDTX), AVADEL PHARMACEUTICALS PLC and CYTOMX THERAPEUTICS INC (CTMX) stocks. They significantly reduced their stock positions in VIRIDIAN THERAPEUTICS INC (VRDN), COGENT BIOSCIENCES INC (COGT) and TERNS PHARMACEUTICALS INC (TERN). Vivo Capital, LLC opened new stock positions in SENSEI BIOTHERAPEUTICS INC (SNSE), ARRIVENT BIOPHARMA INC and AN2 THERAPEUTICS INC (ANTX). The fund showed a lot of confidence in some stocks as they added substantially to ERASCA INC (ERAS), CORVUS PHARMACEUTICALS HOLDINGS (CRVS) and BRIGHT MINDS BIOSCIENCES INC (DRUG).
Vivo Capital, LLC Equity Portfolio Value
Last Reported on: 20 May, 2026
$1.20Billion
  as of May 20, 2026

Vivo Capital, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Vivo Capital, LLC made a return of 17.56% in the last quarter. In trailing 12 months, it's portfolio return was 161.17%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
sensei biotherapeutics inc22,758,100
arrivent biopharma inc20,438,100
veradermics inc18,945,000
an2 therapeutics inc10,785,400
onkure therapeutics inc7,980,720
alx oncology holdings inc6,385,350
satellos bioscience inc4,580,940
compass pathway plc1,106,000
New stocks bought by Vivo Capital, LLC

Additions

Ticker% Inc.
erasca inc31.04
corvus pharmaceuticals holdings25.56
bright minds biosciences inc11.08
dbv technologies sa8.37
praxis precision medicines3.04
Additions to existing portfolio by Vivo Capital, LLC

Reductions

Ticker% Reduced
viridian therapeutics inc-83.08
cogent biosciences inc-82.4
terns pharmaceuticals inc-75.04
geron corp-68.15
soleno therapeutics inc-67.05
dyne therapeutics inc-40.44
abivax sa - adr-33.33
aclaris therapeutics, inc.-25.00
Vivo Capital, LLC reduced stake in above stock

Sold off

Ticker$ Sold
cytomx therapeutics inc-12,288,500
avadel pharmaceuticals plc-57,842,500
palisade bio inc-5,389,910
abeona therapeutics, inc.-9,711,300
verastem inc-8,542,360
silence therapeutics plc-6,721,160
cidara therapeutics, inc.-211,319,000
zenas biopharma inc-30,990,400
Vivo Capital, LLC got rid off the above stocks

Sector Distribution

Vivo Capital, LLC has about 78.5% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare78.5
Others21.5

Market Cap. Distribution

Vivo Capital, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • SMALL-CAP
  • UNALLOCATED
  • MICRO-CAP
  • NANO-CAP
Category%
MID-CAP40.7
SMALL-CAP26.2
UNALLOCATED21.5
MICRO-CAP6.5
NANO-CAP5.1

Stocks belong to which Index?

About 47.4% of the stocks held by Vivo Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others52.6
RUSSELL 200047.4
Top 5 Winners (%)%
ERAS
erasca inc
211.4 %
TNGX
tango therapeutics inc
136.1 %
dianthus therapeutics inc
103.6 %
CRVS
corvus pharmaceuticals holdings
74.0 %
ORIC
oric pharmaceuticals inc
51.4 %
Top 5 Winners ($)$
ERAS
erasca inc
133.5 M
TERN
terns pharmaceuticals inc
41.2 M
TNGX
tango therapeutics inc
26.0 M
CRVS
corvus pharmaceuticals holdings
17.5 M
dianthus therapeutics inc
15.1 M
Top 5 Losers (%)%
PEPG
pepgen inc
-72.8 %
KTTA
pasithea therapeutics corp
-42.5 %
OLMA
olema pharmaceuticals inc
-40.4 %
SERA
sera prognostics inc
-31.2 %
camp4 therapeutics inc
-28.1 %
Top 5 Losers ($)$
PEPG
pepgen inc
-11.0 M
SLNO
soleno therapeutics inc
-7.6 M
camp4 therapeutics inc
-7.3 M
abivax sa - adr
-7.0 M
OLMA
olema pharmaceuticals inc
-6.8 M

Vivo Capital, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Vivo Capital, LLC

Vivo Capital, LLC has 46 stocks in it's portfolio. About 59.3% of the portfolio is in top 10 stocks. PEPG proved to be the most loss making stock for the portfolio. ERAS was the most profitable stock for Vivo Capital, LLC last quarter.

$1.20BTotal Value
55.00Positions
20 May, 2026Last Reported
Current holdings of Current Stock Holdings of Vivo Capital, LLC, last reported on 20 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
CMPS
Compass Pathway Plc

Compass Pathway Plc

CMPS
Vivo Capital, LLC's holding in Compass Pathway Plc over time
0.09%200,000
$1.11M
0.09%
new position
DBVT
Dbv Technologies Sa

Dbv Technologies Sa

DBVT
Vivo Capital, LLC's holding in Dbv Technologies Sa over time
4.63%2,667,570
$55.73M
4.63%
increased 8.37 percentadded
DRUG
Bright Minds Biosciences Inc

Bright Minds Biosciences Inc

DRUG
Vivo Capital, LLC's holding in Bright Minds Biosciences Inc over time
3.38%557,172
$40.66M
3.38%
increased 11.08 percentadded